Clinical Trial Update: Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating chemoradiation with tetrathiomolybdate in esophageal cancer; the study is completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Tetrathiomolybdate (tetrathiomolybdate)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Esophageal Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-08-22